Biblio
2023
Karmali R, Abramson JS, Stephens DM, Barnes JA, Winter JN, Ma S, Gao J, Kaplan J, Petrich AM, Mi X, et al. Ibrutinib Maintenance Following Frontline Treatment in Patients with Mantle Cell Lymphoma. Blood Adv. 2023.
David KA, Sundaram S, Kim S-H, Vaca R, Lin Y, Singer S, Malecek M-K, Carter J, Zayac A, Kim MSun, et al. Older Patients with Primary Central Nervous System Lymphoma: Survival and Prognostication Across 20 US Cancer Centers. Am J Hematol. 2023.
2019
Godfrey JK, Nabhan C, Karrison T, Kline JP, Cohen KS, Bishop MR, Stadler WM, Karmali R, Venugopal P, Rapoport AP, et al. Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019.